These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11092997)

  • 1. Ceftriaxone is an efficient component of antimicrobial regimens in the prevention and initial management of infections in end-stage renal disease.
    Trimarchi H; Lafuente P; Suki WN
    Am J Nephrol; 2000; 20(5):391-5. PubMed ID: 11092997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the efficacy, tolerance and safety of Biotrakson use in patients with kidney failure].
    Rubik J; Grenda R; Dzierzanowska D
    Pediatr Pol; 1995 Dec; 70(12):1043-52. PubMed ID: 8649944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of ceftriaxone in patients with end-stage renal disease and hemodialysis.
    Losno Garcia R; Santivañez V; Battilana CA
    Chemotherapy; 1988; 34(4):261-6. PubMed ID: 3208543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial.
    Del Rio P; Vellone M; Fragapane P; di Millo M; Mazzitelli R; Allegri C; Nuzzo G; Sianesi M
    Acta Biomed; 2008 Apr; 79(1):23-7. PubMed ID: 18551818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections.
    Hoepelman IM; Rozenberg-Arska M; Verhoef J
    Lancet; 1988 Jun; 1(8598):1305-9. PubMed ID: 2897559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preincisional single-dose ceftriaxone for the prophylaxis of surgical wound infection.
    Chalkiadakis GE; Gonnianakis C; Tsatsakis A; Tsakalof A; Michalodimitrakis M
    Am J Surg; 1995 Oct; 170(4):353-5. PubMed ID: 7573727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of ceftriaxone in severe infections in adults].
    Lacut JY; Dupon M; Quentin C; Brachet-Liermain A; Granger C; Echinard E
    Pathol Biol (Paris); 1986 May; 34(5):451-6. PubMed ID: 3534720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose ceftriaxone versus multiple-dose cefuroxime for antimicrobial chemoprophylaxis in pleuropulmonary surgery.
    Ilic N; Petricevic A; Kotarac S; Perisic R
    Panminerva Med; 1997 Sep; 39(3):240-3. PubMed ID: 9360431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
    Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
    Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
    Nonikov VE; Konstantinova TD; Makarova OV; Manziuk EN; Minaev VI; Ritchik LA
    Ter Arkh; 1997; 69(10):84-8. PubMed ID: 9471801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
    Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
    Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the penetration of ceftriaxone into cerebrospinal fluid].
    Hattori T; Kobayashi H; Uno T
    Jpn J Antibiot; 1996 Aug; 49(8):813-7. PubMed ID: 9053536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infections.
    Chaudhary M; Shrivastava SM; Sehgal R
    Curr Drug Saf; 2008 Jan; 3(1):82-5. PubMed ID: 18690985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T; Jakobs R; Riemann JF
    Hepatogastroenterology; 2004; 51(58):941-5. PubMed ID: 15239219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.